2 Articles
2 Articles
All
Left
Center
1
Right
Tandem, Abbott to pair insulin pumps with glucose-ketone monitor
The Tandem Diabetes Care Mobi pump (left) and Abbott FreeStyle Libre 3 (right). [Images courtesy of the companies]Tandem Diabetes Care (Nasdaq:TNDM) today announced an agreement to develop and commercialize diabetes tech with Abbott (NYSE:ABT). San Diego-based Tandem said it agreed to combine its insulin delivery systems with Abbott’s future dual glucose-ketone sensor. The companies aim to provide more options for people to manage their diabetes…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium